Biosimilar Insulin Market to exhibit high growth over the coming years a value CAGR of 14.9% by the end of 2032 – Persistence Market Research New York, July 14, 2022 (GLOBE NEWSWIRE) -- The biosimilar insulin market reached US$ 1.3 Bn at the end of 2021 and is expected to surge ahead at a CAGR of 14.9% over the forecast period...